Olopatadine Formulations For Topical Nasal Administration

  • Published: Aug 14, 2008
  • Earliest Priority: Feb 07 2007
  • Family: 20
  • Cited Works: 0
  • Cited by: 1
  • Cites: 3
  • Additional Info: Full text
Abstract

Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6 % (w/v) of olopatadine.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 14, 2008
  • Application: Feb 7, 2007
    WO US 2007/0003285 W
  • Priority: Feb 7, 2007
    US US 2007/0003285 W

Sign in to the Lens

Feedback